Opdualag

Opdualag™

Opdualag™ (nivolumab and relatlimab-rmbw) is a medicine that may treat a type of skin cancer called melanoma by working with your immune system

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Opdualag™ Referral Form

MANUFACTURER:

Bristol Myers Squibb

CLASS:
LAG-3 inhibitor
WHAT IT TREATS:
PRESCRIBED BY:

Oncologists

HOW ADMINISTERED:
IV Infusion
FREQUENCY:

Every four weeks

Length of infusion:
30 mins